Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05711108 · ClinicalTrials.gov registry record
Continuous Glucose Monitoring (CGM) in Long Term Care (LTC) Facilities
A clinical trial, sponsored by Joslin Diabetes Center.
- Completed
- Registry status
- 86
- Enrollment target
NCT05711108: Completed study, sponsored by Joslin Diabetes Center.
NCT05711108 is a clinical trial that has completed, run by Joslin Diabetes Center. The registered enrollment target is 86 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05711108 has completed, sponsored by Joslin Diabetes Center.
- COMPLETED
- Registry status
- 86 participants
- Enrollment target
Study Summary
To prospectively determine the burden of hypoglycemia (minutes spent below 70 mg/dl per day, measured by continuous glucose monitor (CGM)) among residents of long term care facilities (LTC) with a diagnosis of type 1 or type 2 diabetes including key clinical subgroups (living in skilled nursing facility (SNF) or nursing home (NH), on different hypoglycemic medications). This aim will be achieved by recruiting 300 residents with diabetes in 4 LTC facilities. All participants will undergo masked CGM for 10 days.
Primary Outcome
minutes per day sensor glucose \<70 mg/dL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2022-01-19 |
| Est. Completion | 2024-12-31 |
What the finished NCT05711108 record still lists
NCT05711108 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 86 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05711108 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05711108 about?
NCT05711108 is a clinical study titled "Continuous Glucose Monitoring (CGM) in Long Term Care (LTC) Facilities". To prospectively determine the burden of hypoglycemia (minutes spent below 70 mg/dl per day, measured by continuous glucose monitor (CGM)) among residents of long term care facilities (LTC) with a diagnosis of type 1 or type 2 diabetes including key clinical subgroups (living in skilled nursing faci...
What is the current status of trial NCT05711108?
This trial is currently completed. The enrollment target is 86 participants. The study started on 2022-01-19. Estimated completion is 2024-12-31.
Who is sponsoring clinical trial NCT05711108?
This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01639508 · 86 participants · Phase 2
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- NCT03519269 · 86 participants · NA
Navio Robotic Versus Conventional Total Knee Arthroplasty
- NCT04132999 · 86 participants · NA
PAP for Children With DS and OSAS
- NCT04545957 · 86 participants · NA
Jump: MR Simulation For Radiation Therapy Master Protocol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI